Edwards Lifesciences Corp — Director's Dealing 2012

May 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-05-11

Reporting Person: Solomon Carlyn D (CVP, Critical Care & Vascular)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-11	Common Stock	M	44800.0000	$27.7700	Acquired	76856.0000	Direct
2012-05-11	Common Stock	M	28500.0000	$31.4700	Acquired	105356.0000	Direct
2012-05-11	Common Stock	S	73300.0000	$84.6900	Disposed	32056.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-11	Employee Stock Option (Right to Acquire)	$31.4700	M	28500.0000	Disposed	2016-05-06	Common Stock (28500.0000)	Direct
2012-05-11	Employee Stock Option (Right to Acquire)	$27.7700	M	44800.0000	Disposed	2015-05-07	Common Stock (44800.0000)	Direct

Footnotes

F1: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.

F2: This transaction was executed in multiple trades at prices ranging from $84.55 to $84.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.